UK Hospital to invest 17000 crore in India to give boost to Indian Medical Tourism

It is the headquarters for 11 such hospitals being set up in India

Laying the foundation for King’s College Hospital (KCH) – IUIH (Indo-UK Institute of Health) Medicity coming up at Navuluru in Guntur district on Wednesday, Chief Minister N. Chandrababu Naidu gave a further boost to the transformation of Amaravati into a medical tourism hub.

He thanked KCH Chairman Lord Robert Kerslake, and IUIH Managing Director and CEO Ajay Rajan Gupta for agreeing to make the facility coming up in Amaravati, the headquarters for 11 such hospitals being established in India at a cost of Rs. 17,000 crore.

Mr. Naidu said he was indebted to the farmers who gave their lands for the construction of the capital city, which was attracting global talent, and investments into projects like the KCH-IUIH Medicity.

R&D units

Apart from a medical university, the KCH-IUIH Medicity would have dedicated oncology and cancer liver transplantation centres and a host of R&D units.

The Chief Minister said the All India Institute of Medical Sciences (AIIMS) being set up at Mangalagiri, a world-class hospital proposed to be established by L.V. Prasad Eye Institute and 13 medical colleges which are on the anvil in the capital region bear testimony to the fact that Amaravati was the most happening place as far as the healthcare sector was concerned.

Lord Robert Kerslake said the Amaravati project was a significant step in the collaboration of the Indian and British governments, for the development of healthcare in India.

The partnership began during Prime Minister Narendra Modi’s visit to London when he sought the cooperation of his counterpart at that time, David Cameron, for improving healthcare facilities in India with the support of UK’s National Health Services, which is rated as one of the best in the world.

Union Minister’s promsie

Union Minister of State for Health and Family Welfare Anupriya Patel said the KCH-IUIH Medicity at Amaravati was the second one to have the foundation laid for, the first one being Nagpur, and promised to extend all possible help for implementation of the projects.

Member of Parliament of UK Andrew Mitchell, First Secretary of International Trade of the British High Commission Haden Spicer, British Deputy High Commissioner Bharat Joshi and A.P. Ministers Kamineni Srinivas and P. Narayana were present.

Advertisements

Why Hungary is number one destination for Dental Tourism

1)Connected to seven neighboring countries

2)Seven International Airports

3)Government provides financial support to Dental Clinics

4)Started Dental Tourism 30 years back

5)Highest number of per capita dentists.Ratio of dentists to population is very high

6)Located in Richest continent Europe

7)Budapest is the most beautiful city in the world

Increase in Medical Tourism Visa for India

The number of medical visas issued by India rose 45% in 2016 from the year before, data presented by the home affairs ministry in Rajya Sabha on Wednesday showed, an indication that India is rapidly becoming a hub of medical treatment for foreigners.

India issued more than 1.78 lakh medical visas in 2016, including for follow up treatment, as against 1.22 lakh in 2015, according to the data.

In 2014, there were 184,298 Foreign Tourist Arrivals (FTA), in 2015 the number was 233,918 which jumped to 361,060 in 2016, according to the Ministry of Tourism.

A Confederation of Indian Industry (CII) report titled “India Services Sector—A Multi-trillion Dollar Opportunity for Global Symbiotic Growth 2017” stated that the presence of world-class hospitals and skilled medical professionals has strengthened India’s position as a preferred destination for medical tourism. Treatment for major surgeries in India costs only a fraction—in some cases as low as 10% of that in developed countries.

“Majority of the patients coming to India for treatment are from the Middle East, Africa, Bangladesh, Afghanistan, Maldives, Pakistan, Bhutan and Sri Lanka. India’s cost advantage will significantly open doors to the US and Europe over future, due to lower cost than the US and almost half that of Europe.”

Dental tourism accounts for 10% of the medical tourism and the government is keen to promote it. “India provides competitive cost advantage at one tenth of the cost of the US and Europe. By 2020, medical tourism industry of India is expected to touch $8 billion,” the report said.

“Government’s support for medical tourism is appreciated. Various medical areas are sought after in India. When it comes to cosmetic surgeries, doctors are surely doing great work in India.

The ministry of tourism has recently released revised guidelines for the promotion of wellness and medical as niche tourism product. As per the guidelines, the ministry offers financial support to accredited Medical and Wellness Tourism Service Providers, Chambers of Commerce and other organisations as Marketing Development Assistance, for Publicity, organising workshops/events/seminars and for organising Wellness and Medical Tourism Promotion shows.

There is also a growing demand for Indian medical talent and know-how in geographies that are lacking in advanced medical infrastructure, and several players in African countries are approaching Indian players to help them set up and run hospitals, both as advisors as well as O&M partners. This is adding to the ‘exports’ bucket, the CII report said.

India now has a simplified e-medical visa facility which allows three visits to the country. Dr. Mahesh Sharma, minister of state for tourism and culture, recently said at a medical tourism summit that the government is trying to address more issues in the time to come, such as standardization and accreditation of services.

Ayush boosting Wellness Tourism in India

Reviving traditional medicine system, such as Ayush, has helped boost India’s medical tourism market in comparison to western nations, surviving only on modern medicinal system, health experts said here on Sunday.

Observing that despite many recent policy changes, such as demonetisation and GST, the flow of foreign patients in India is increasing, the experts said the major reason for this is alternative medical solutions such as Ayush (Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy) which is available only in India.

South Asian Medical Tourism Market growing

Thailand can emerge as the region’s top medical tourism hotspot, as the country attracts 550,000 Asean medical tourists yearly, according to Gernot Ringling, managing director of the trade fair organiser Messe Dusseldorf Asia. “Across the region, medical tourism is on the rise with more than 3.5 million consumers arriving in Southeast Asia annually. “Globally, the medical tourism market is expanding by up to 25 per cent each year and is worth more than US$55 billion (Bt1.8 trillion) annually.
“Out of the more than 11 million global medical consumers, nearly a third travel to Southeast Asia,” said Ringling. As Southeast Asia’s public and private health systems are increasingly embracing and funding technology enabled care to follow their European and North American counterparts, advanced technologies that can deliver scalable, efficient and highquality care are becoming increasingly popular in the region.
For instance, the increasing use of robotic surgery, 3D printing, implantable devices, use of automation and artificial intelligence in clinical settings, and other digital innovations for prevention, monitoring and treatment are among the hottest products and solutions and trends across Southeast Asia.

India to capitalise on Singapore’ns Medical Tourism slowing Down

THE GROWTH of medical tourism in Singapore is expected to slow down amid stiffer regional competition, especially from the Malaysian healthcare market, according to investment bank UOB Kay Hian.

The softer outlook in Singapore comes amid a decline in growth of foreign-patient numbers. This, in turn, is expected to take a toll on growth in revenue. Foreigners made up 40 per cent of IHH Healthcare’s business in Singapore in 2013, but this fell to 30 per cent last year. Its quarterly revenue growth in the same period has also declined from an average of 5 per cent year on year between 2013 and 2014 to between 1 and 2 per cent year on year from 2015 to 2016.
With the sector’s stronger showing in Malaysia, UOB Kay Hian analysts singled out Health Management International (HMI) as a top pick with strong growth prospects. The firm is behind Regency Specialist Hospital in Johor and Mahkota Medical Centre in Melaka. The positive outlook in Malaysia has been “bolstered by favourable government initiatives, geographical proximity and cultural affinity to its largest market, Indonesia”, the analysts wrote.
Patients are flocking to Malaysia thanks to factors such as improvements in infrastructure and service quality, as well as the relatively lower hospital bills, they said. “Comparing private hospitals under our coverage, we note average bill sizes at HMI’s hospitals are approximately 15-30 per cent of Singapore’s. “Furthermore, a weak ringgit may also be a silver lining that can help Malaysia gain price advantage over its regional peers for medical tourism purposes.” A Maybank Kim Eng report this month noted that Singapore was the second-priciest medical-tourism destination in the world, and the most expensive in Asia. On the back of a rise in the number of medical tourists headed to Malaysia – from 643,000 in 2011 to 921,000 last year – UOB Kay Hian analysts expect Malaysian revenue intensity to climb as well. The sector is anticipated to hit its target revenue of 1.3 billion ringgit (Bt10.3 billion) this year. Meanwhile, UOB Kay Hian has reservations about near- to mid-term prospects for IHH and Raffles Medical Group (RMG), over the costs of their expansion into the Chinese market.China eyed “Besides diversifying the concentration of medical patients to include [the] Middle East as well as the Indochina regions, Singapore hospital operators have embarked on more aggressive expansion strategies, prominently in Greater China,” its analysts wrote. “While we view these expansions positively, we expect start-up costs to crimp earnings growth in the near- to mid-term.” The analysts added while IHH had “resilient operations” in Singapore, Malaysia and Turkey and new ventures in markets such as China and India, “the stock is fairly valued” and has been priced in. Similarly, a CIMB forecast for RMG last week said the cost of new hospital expansions might have been underestimated.